However, few reports have characterized MDV-1 strains isolated in Japan. In this study, we established the amino acid sequences of MDV-1 field isolates from Japan in order to determine whether they display a distinct diversity of and point mutations in Meq. In addition, we analyzed the transactivation activities of the Meq proteins in order to evaluate whether the observed mutations affect their functions. Japanese MDV-1 isolates displayed the distinct mutations in basic region 2 (BR2) and proline-rich repeats (PRRs) of the Meq proteins as well as some unique mutations. Reporter assays revealed that the amino acid substitutions in BR2 and the PRRs affected the Meq transactivation activity. These results suggest that the distinct mutations are also present in the Meq proteins of MDV-1 isolates from Japan and affect their transactivation activities.
Introduction
Marek's disease virus (MDV: family, Herpesviridae; subfamily, -Herpesvirinae; genus, Mardivirus; species, Gallid herpesvirus 2) is the causative agent of Marek's disease (MD), which manifests as malignant lymphomas in infected chickens (Calnek and Witter, 1997) .
MDV strains had been previously classified as serotypes but are currently reclassified as species: GaHV-2 (MDV serotype 1 (MDV-1)), Gallid herpesvirus 3 (MDV serotype 2), and
The molecular mechanisms of MDV-1 oncogenicity and pathogenicity have been difficult to elucidate due to the lack of appropriate chicken T cell transformation systems. The search for viral factors related to MDV-1-induced latency and tumorigenicity identified the viral protein Meq as a putative oncoprotein (Jones et al., 1992) . Meq is present only in MDV-1 strains and is consistently expressed in MDV-1-transformed cell lines and tumor samples (Peng and Shirazi, 1996; Peng et al., 1995; Qian et al., 1995; Ross et al., 1997) . The meq gene encodes a 339-amino acid protein with an N-terminal basic region leucine zipper (bZIP) domain and a C-terminal transactivation domain ( Fig. 1 ) (Liu and Kung, 2000) . The bZIP domain, similar to that of the Jun/Fos family of oncoproteins, consists of 2 stretches of basic residues (basic regions 1 and 2 (BR1 and BR2)) and a leucine zipper (Liu and Kung, 2000) .
The transactivation domain is characterized by 2.5 proline-rich repeats (PRRs), which contain several SH3-binding motifs (Liu and Kung, 2000) . The overexpression of Meq in rodent and chicken fibroblast cell lines produced morphological changes and protected the expressing cells from apoptosis Levy et al., 2005; Liu et al., 1998) .
Microarray analysis determined that the genes induced by v-Jun transformation, including JTAP1, JAC, and HB-EGF, were also upregulated by the expression of Meq in transformed DF-1 cells (Levy et al., 2005) . In addition, Meq also upregulated the expression of Bcl-2 and Ski and downregulated the expression of DAP5 and Fas, a pattern consistent with an anti-apoptotic effect (Levy et al., 2005; Liu et al., 1998) . Moreover, a meq-null recombinant mutant virus was completely nononcogenic (Lupiani et al., 2004) . These observations strongly suggest that Meq plays a key role in the oncogenicity of MDV-1.
Several factors that could contribute to the enhanced virulence of MDV-1 field isolates have been identified (Chang et al., 2002; Lee et al., 2000; Shamblin et al., 2004) . The most important of these findings were the distinct diversity of and mutations in the Meq proteins of highly virulent MDV-1 strains, especially in basic region 2 (BR2) and the proline rich repeats (PRRs) in the transactivation domain. The PRRs exhibit a transrepression effect, whereas the BR2 is involved in the nuclear and nucleolar localization and the DNA binding of Meq (Liu and Kung, 2000) . Therefore, the mutations in BR2 and the PRRs may influence the transcriptional activity of Meq. Indeed, we recently showed that a proline-to-alanine substitution at position 217 of Meq, which is in the PRRs, enhanced Meq transactivation activity (Murata et al., 2011) . Therefore, the distinct diversity of and point mutations in the Meq proteins could contribute to their transactivation activities and, consequently, may be responsible for the increased oncogenicity of these MDV-1 strains.
In this study, we investigated the amino acid sequences of the Meq proteins of MDV-1 field isolates collected in Japan from the early 1980s-2010. Comparison of the amino acid sequences of old and new isolates showed that the distinct diversity and point mutations were present in BR2 and the PRRs of the Meq proteins of field isolates in Japan. In addition, we evaluated the transactivation activities of these Meq proteins using dual luciferase reporter assays in order to determine whether the mutations affect Meq function. Our reporter assays revealed that the amino acid substitutions in BR2 and the PRRs contribute to the enhanced transactivation activities of the Meq proteins, and influence of the amino acid substitutions in BR2 seems to be dominant compared with those in the PRRs. These results suggest that the distinct diversity and point mutations are present in the Meq proteins of field isolates from Japan and affect their transactivation activities.
Materials and Methods

Sample collection
Samples were collected from the early 1980s-2010 from poultry farms in Japan at which some chickens had developed MD symptoms. Samples from internal organs and/or feather tips of MDV-infected chickens were used for the detection and sequencing analysis of the meq genes.
DNA sequencing
Total cellular DNA samples were extracted from feather tips as previously described (Murata et al., 2007) and from internal organs by using SepaGene (Sankojunyaku, Tokyo, Japan) according to the manufacturer's instructions. Total cellular DNA samples were used as templates for PCR using meq-specific primer sets. PCR was performed with the primer set M-S (5′-ATGTCTCAGGAGCCAGAGCCGGGCGCT-3′) and M-AS (5′-GGGGCATAGACGATGTGCTGCTGAG-3′). Amplification was performed using 35 cycles of 94°C for 45 sec, 57°C for 45 sec, and 72°C for 1.5 min. The nucleotide sequences of the amplified meq genes were determined. The PCR products were gel-purified and cloned into the pGEM-T easy vector (Promega, Madison, WI). The plasmid containing the insert was purified by a standard mini-prep method and sequenced using the CEQ 2000 Dye Terminator Cycle Sequencing method and the Quick Start kit (Beckman Coulter, Fullerton, CA) according to the manufacturer's instructions. The obtained sequences were analyzed using the CEQ 2000 DNA analysis system (Beckman Coulter, Fullerton, CA).
Construction of expression plasmids
To construct Meq expression plasmids, total cellular DNA was extracted from each field sample or from chicken embryo fibroblasts infected with the vv MDV-1 strain RB1B (Schat et al., 1982) , and the open reading frames (ORFs) of the meq genes were amplified from these samples by PCR using primers M-S-EcoRI and M-AS-NotI, which have the same sequences as M-S and M-AS but contain an EcoRI and a NotI site, respectively, at their 5′ ends. The amplified meq ORFs were digested with EcoRI and NotI. The digested fragments were cloned into the EcoRI and NotI sites of the pCI-neo vector (Promega, Madison, WI) to construct expression plasmids for wild type Meq from RB1B and field samples. In addition, a c-Jun expression plasmid was constructed as previously described (Okada et al., 2007) . In brief, the chicken c-jun transcript was also amplified by PCR using primers cJ-S-XhoI (5′-CTCGAGAAGATGGAGCCTACTTTCTACGA-3′) and cJ-AS (5′-GTTTGGTTATACCACAACATCACAG-3′). The amplified fragments were subcloned into the pGEM-T easy vector (Promega, Madison, WI) and digested with XhoI and NotI.
The digested fragments were cloned into the XhoI and NotI sites of the pCI-neo vector.
Introduction of point mutations into Meq expression plasmids
All point mutations were introduced into plasmids expressing wild type Meq from RB1B using the QuickChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA) according to the manufacturer's instructions. The primers used to introduce the point mutations are shown in Table 1 . 
Dual luciferase reporter assay
Statistics
All values in figures are expressed as mean ± standard deviation. Statistical comparison was performed by analysis of variance followed by paired 2-group t test.
Results
Distinct diversity of the Meq proteins from MDV-1 field isolates in Japan
To determine whether the Meq proteins of MDV-1 field samples from Japan exhibit distinct diversity and point mutations, we obtained their nucleotide sequences and established their deduced amino acid sequences. Upon aligning the deduced amino acid sequences, we found the distinct mutations at each position in the Meq protein reported by Shamblin et al. (2004) , including the distinct mutations at positions 77 and 80 in BR2, position 115, and position 217 in the PRRs (Table 2 ). In addition, some samples also contained unique mutations at positions 174, 176, and 193: a threonine-to-asparagine substitution at position 174, a proline-to-serine/leucine substitution at position 176, and a proline-to-serine substitution at position 193. The amino acid sequences of the Meq proteins analyzed in this study were classified into 6 groups ( Table 3 ). The Meq proteins detected in relatively old isolates (from the early 1980s) had serine at position 193, whereas the Meq proteins detected in most of the recent field samples had proline at position 193. In contrast to the older isolates, the Meq proteins of some recent samples had lysine at position 77 and aspartate at position 80 in BR2 or serine/leucine at position 176 in the PRRs.
Transactivation activities of the Meq proteins from field samples
The observed substitutions at positions 174, 176, 193 , and 217 of Meq were located in the PRRs of the transactivation domain. We recently reported that a proline-to-alanine substitution at position 217 in the PRR could affect the transactivation function of the Meq protein (Murata et al., 2011) . Therefore, the substitutions observed in the PRRs may affect the transactivation activities of the Meq proteins. In addition, we confirmed that the amino acid substitutions at positions 77 and 80 in BR2 affected the transactivation activities of the Meq proteins (in preparation for the submission). To determine whether the observed substitutions in the Meq proteins affect their transactivation activities, the transactivation activity of each Meq was analyzed by a dual luciferase reporter assay using corresponding mutant Meq expression plasmids. In this study, we used the Meq promoter to evaluate the transactivation activities of the Meq proteins and performed co-transfections with Meq and c-Jun expression plasmids because these proteins can form a heterodimer that activates the Meq promoter (Levy et al., 2003) . The transactivation activities of RB1B-and Nig-c1-Meq were almost the same, which was expected as they have the same amino acid sequence (Fig.   2 ). The transactivation activity of Tkc-c1-Meq was higher than that of RB1B-Meq, indicating that a proline-to-alanine substitution at position 217 could enhance transactivation activity (Fig. 2) . The transactivation activities of the Meq proteins of Isk-c1, Gf-c1, MD239, and MD242 were very similar to but lower than that of RB1B-Meq (Fig. 2) . Although the distinct mutations at positions 174, 176, or 193 were present in the PRRs of the Meq proteins of Isk-c1, Gf-c1, MD239, and MD242, these proteins displayed no differences in transactivation activity (Fig. 2) . Thus, the transactivation activities of the Meq proteins were affected by the amino acid substitution at position 217 in the PRRs when the amino acid residues were lysine, aspartate, and valine at positions 77, 80, and 115, respectively. On the other hand, the transactivation activities of the Meq proteins were similar when the amino acid residues were glutamic acid, tyrosine, and alanine at positions 77, 80, and 115, respectively. Therefore, the influence of the amino acid substitutions at position 115 or in BR2 on the functions of the Meq proteins may be dominant compared with those at positions 174, 176 and 193 in the PRRs.
Transactivation activities of RB1B-Meq proteins with point mutations
To determine whether the difference observed in the transactivation activities between RB1B-Meq and the Meq proteins of Isk-c1, Gf-c1, MD239, and MD242 depend on the amino acid substitutions at position 115 or in BR2, we constructed mutant RB1B-Meq expression plasmids and analyzed the transactivation activities of the resulting proteins. The transactivation activities of wild type RB1B-Meq and mutant RB1B-Meq with a valine-to-alanine substitution at position 115 (RB1B-Meq (V115A)) were almost the same, indicating that the transactivation activity of Meq was unaffected by the amino acid substitution at position 115 (Fig. 3) . In order to determine whether the amino acid substitutions in BR2 affect the transactivation activity, we compared the transactivation activities of wild type RB1B-Meq, a mutant RB1B-Meq protein with a proline-to-leucine substitution at position 176 (RB1B-Meq (P176L)), another Meq protein with a lysine-to-glutamic acid substitution, an aspartate-to-tyrosine substitution, and a proline-to-leucine substitution at positions 77, 80, and 176, respectively (RB1B-Meq (K77E, D80Y, P176L)), and Gf-c1-Meq (Fig. 4) . The transactivation activity of RB1B-Meq (K77E, D80Y, P176L) was lower than that of wild type RB1B-Meq or RB1B-Meq (P176L) and similar to that of Gf-c1-Meq. No difference in the transactivation activities of wild type RB1B-Meq and RB1B-Meq (P176L) was observed, suggesting that a proline-to-leucine substitution at position 176 could not affect the transactivation activity. In addition, no difference in the transactivation activities of RB1B-Meq (K77E, D80Y, P176L) and Gf-c1-Meq was observed, although Gf-c1-Meq had a proline-to-alanine substitution at position 217. These results suggest that the amino acid substitutions in BR2 and the PRRs contribute to the enhanced transactivation activities of the Meq proteins, and the distinct mutations in the BR2 may predominantly affect the transactivation activity.
Discussion
MDV-1 is one of the potent oncogenic herpesviruses (Calnek and Witter, 1997) . MDV-1 field isolates in various countries have tended to increase in virulence over time, but MDV-1 isolates from Japan had not previously been characterized. To date, several viral factors that could relate to the enhanced virulence of MDV-1 have been identified. Among them, one notable finding was that the distinct diversity of and point mutations in the Meq protein, which is the most important molecule in MDV-1 oncogenicity, correlate with the level of virulence (Chang et al., 2002 , Lee et al., 2000 , Shamblin et al., 2004 . Meq is associated with latent infection and involved in the transformation of lymphocytes but is not essential for cytolytic infection in the lymphoid organs and the feather follicular epithelium (Lupiani et al., 2004) . Therefore, the distinct mutations in the Meq proteins may affect MDV-1 oncogenicity and thereby correlate with MDV-1 virulence. In this study, we established the deduced amino acid sequences of the Meq proteins of MDV-1 field isolates from Japan. In addition, since Meq contributes to MDV-1-mediated transformation by altering the expression of various cellular genes (Brown et al., 2009; Levy et al., 2003 Levy et al., , 2005 Shchodolski et al., 2009 Shchodolski et al., , 2010 , we analyzed the transcriptional functions of the Meq proteins of field isolates from Japan.
Previous studies in which the deduced amino acid sequences of the Meq proteins were aligned have noted some trends with respect to mutations and virulence (Shamblin et al., 2004) . Lower-virulence MDV-1 strains showed point mutations at positions 77 and 80 in BR2. In addition, some low-virulence MDV-1 strains tended to include an amino acid insertion in the transactivation domain and an increased number of PRRs. Higher-virulence MDV-1 strains had point mutations at positions 153, 176, and 217 in the PRRs that interrupted stretches of four prolines at position 2. In this study, we found that some MDV-1 strains recently isolated in Japan had the same substitutions in BR2 and the PRRs, whereas the Meq variant including the amino acid deletion or insertion was not detected. Some field isolates contained the previously reported substitutions in BR2: a glutamic acid-to-lysine substitution at position 77 and a tyrosine-to-aspartate substitution at 80. In addition, some of the Meq proteins also had the substitutions in the PRRs: a proline-to-leucine/serine substitution at position 176 and a proline-to-alanine substitution at 217. However, to date the substitutions at position 176 have only been detected in recent Japanese isolates.
According to a recent report, a proline-to-arginine substitution at 176 was found in MDV-1 strains isolated in China (Zhang et al., 2011) . Therefore, the patterns of the substitutions in the Meq proteins of field isolates seem to vary among countries, although the positions at which the substitutions were observed were almost the same. These observations suggest that different MDV-1 strains are prevalent in each country.
Among recent field isolates from Japan, the amino acid substitutions were observed in BR2 of the Meq proteins of Nig-c1, Kgw-c1, and Tkc-c1. We confirmed that the substitutions at positions 77 and 80 in BR2 could affect the transactivation activity and transformation capability (in preparation for the submission). In this study, the Meq proteins of RB1B, Tkc-c1, and Nig-c1 (K and D at positions 77 and 80) exhibited higher transactivation activities than other Meq proteins (E and Y at positions 77 and 80). These results indicate that the substitutions in BR2 are also found in the Meq proteins of recent field isolates from Japan and could affect the transactivation activity. On the other hand, the BR2 amino acid substitutions were not found in the old field isolates analyzed in this study.
Therefore, MDV-1 field isolates from Japan may also have increased in virulence due to enhanced Meq-mediated oncogenicity.
We recently reported that a proline-to-alanine substitution at position 217 could affect Meq transactivation activity when the combination of amino acid residues at positions 283 and 320 was alanine and isoleucine, or valine and threonine, respectively (Murata et al., 2011) .
Indeed, the transactivation activity of Tkc-c1-Meq (A, V, T at positions 217, 283, 320) was higher than that of RB1B (P, A, I at positions 217, 283, 320) in this study (Fig. 2) . However, no difference in transactivation activity was observed between mutated RB1B-Meq (K77E, D80Y, and P176L) and Gifu-c1-Meq, although the amino acid residue at position 217 of Gf-c1-Meq was alanine (Fig. 4) . These results suggest that the influence of the amino acid substitutions in BR2 on the functions of the Meq proteins may be dominant compared with that at position 217 in the PRRs. On the other hand, no difference was observed in the transactivation activities between RB1B (P176L) and RB1B-Meq (Fig. 4) , although the combination of the amino acid residues at positions 77 and 80 was lysine and aspartate. Therefore, the amino acid substitution at position 176 may not affect the transactivation activity. In addition, we found that the amino acid substitutions at position 193 in the PRRs may not affect the transactivation activity when the amino acid residues at positions 77 and 80 were glutamic acid and tyrosine, respectively, as no difference in the transactivation activity was observed among the Meq proteins of Isk-c1, Gf-c1, MD239, and MD242 (Fig. 2) . Therefore, the amino acid substitutions in the PRRs may affect the transactivation activity only in combination with substitutions in BR2, although further studies are needed to clarify the influence of the combination of amino acid substitutions in BR2 and the PRRs on the transactivation activity of the Meq proteins. However, the amino acid residue at position 193 was proline in recent field isolates but serine in old isolates; in addition, the proline-to-serine/leucine substitution at position 176 was only observed in most of Meq proteins from recent field isolates. Therefore, comparison of the Meq proteins of old and recent isolates revealed obvious trends in the substitutions at positions 176 and 193 in the PRRs, and these substitutions may therefore correlate with the transformation capabilities of the Meq proteins. Further studies are required to determine whether these substitutions affect the transformation ability. In addition, in vivo studies using molecular clones would be required to confirm whether these substitutions affect the virulence of MDV-1.
We previously reported that a 59 or 60-amino acid insertion was found in the PRRs of the Meq proteins encoded by CVI988 and CVI988/R6 (Lee et al., 2000) , and this insertion increased the copy number of the PRRs. This longer Meq protein, termed L-Meq, was not detected in vvMDV and vv+MDV strains. whereas L-Meq-encoding strains, such as CU-2, BC-1, and JM, are classified as low-virulence m or vMDV (Shamblin et al., 2004) . The transactivation activity of L-Meq was significantly lower than that of Meq (Chang et al., 2002) . In this study, we found that the amino acid substitutions in BR2 and the PRRs contribute to the enhanced transactivation activities of the Meq proteins, and the distinct mutations in the BR2 could predominantly affect the transactivation activity compared with those in the PRRs. Since the amino acid residues at positions 77 and 80 in BR of CVI988-L-Meq were glutamic acid and tyrosine (Shamblin et al., 2004) , the amino acid substitutions in BR may also contribute to the reduced transactivation activity. However, we could not deny a possibility that the amino acid insertion in PRRs of L-Meq affect the transactivation activity and transformation capability. Therefore, further studies are needed whether the insertion of the PRRs or the amino acid substitutions in BR could be responsible for the reduced transactivation activity observed in L-Meq.
Conclusion
In the present study, we characterized Meq proteins from field isolates in Japan, and as previously reported, we found that the distinct diversity exists in the Meq proteins of MDV-1 strains recently isolated in Japan, and some of these mutations enhanced Meq transactivation activity. In addition, we also found the obvious trends in substitutions at positions 176 and 193, and these substitutions were unique to Japanese isolates. Therefore, the recent MDV-1 strains prevalent in Japan are different from old strains in Japan and those of other countries, and some mutations in the Meq proteins from recent isolates seem to affect their transcriptional activities. Luciferase activities were analyzed 24 h post-transfection, and firefly luciferase activity was 36 expressed relative to the mean basal activity in the presence of pCI-neo after normalization to 37
Renilla luciferase activity. The lower panel indicates the amino acid residues at each 38 position in the Meq proteins. Three independent experiments were performed in triplicate. 39
Error bars indicate standard deviations. 40 Table 1 Primers used for the construction of mutant Meq expression plasmids. 
